RESUMO
Regulatory immunity that provides resistance to relapse emerges during resolution of experimental autoimmune uveitis (EAU). This post-EAU regulatory immunity requires a melanocortin 5 receptor (MC5r)-dependent suppressor antigen presenting cell (APC), as shown using a MC5r single knock-out mouse. The MC5r-dependent APC activates an adenosine 2A receptor (A2Ar)-dependent regulatory Treg cell, as shown using an A2Ar single knock-out mouse. Unexpectedly, when MC5r-/- post-EAU APC were used to activate A2Ar-/- post-EAU T cells the combination of cells significantly suppressed EAU, when transferred to EAU mice. In contrast, transfer of the reciprocal activation scheme did not suppress EAU. In order to explain this finding, MC5r-/-A2Ar-/- double knock-out (DKO) mice were bred. Naïve DKO mice had no differences in the APC populations, or inflammatory T cell subsets, but did have significantly more Treg cells. When we examined the number of CD4 and CD8 T cell subsets, we found significantly fewer CD8 T cells in the DKO mice compared to WT and both single knock-out mice. DKO mice also had significantly reduced EAU severity and accelerated resolution. In order to determine if the CD8 T cell deficiency contributed to the resistance to EAU in the DKO mice, we transferred naïve CD8 T cells from WT mice, that were immunized for EAU. Susceptibility to EAU was restored in DKO mice that received a CD8 T cell transfer. While the mechanism that contributed to the CD8 T cell deficiency in the DKO mice remains to be determined, these observations indicate an importance of CD8 T cells in the initiation of EAU. The involvement of CD4 and CD8 T cells suggests that both class I and class II antigen presentation can trigger an autoimmune response, suggesting a much wider range of antigens may trigger autoimmune disease.
Assuntos
Doenças Autoimunes/imunologia , Linfócitos T CD8-Positivos/imunologia , Receptor A2A de Adenosina/imunologia , Receptores de Melanocortina/imunologia , Uveíte/imunologia , Animais , Autoimunidade/imunologia , Linfócitos T CD4-Positivos/imunologia , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Knockout , Receptor A2A de Adenosina/deficiência , Receptores de Melanocortina/deficiênciaRESUMO
Hypothalamic obesity represents a rare diagnosis applicable to only a small subset of obese patients. It is important to identify, diagnose, and treat these patients. This article reviews the physiology of the hypothalamus, focusing on its role in regulation of hunger, feeding, and metabolism. The causes of hypothalamic obesity are discussed including genetic, anatomic, and iatrogenic etiologies. The complex hormonal environment leading to obesity is explored for each etiology and treatment strategies are discussed. Reproductive consequences are also reviewed.
Assuntos
Doenças Hipotalâmicas/complicações , Hipotálamo/fisiopatologia , Obesidade/etiologia , Apetite/fisiologia , Depressores do Apetite/uso terapêutico , Cirurgia Bariátrica , Craniofaringioma/complicações , Craniofaringioma/cirurgia , Metabolismo Energético/fisiologia , Comportamento Alimentar/efeitos dos fármacos , Comportamento Alimentar/fisiologia , Humanos , Hiperfagia/etiologia , Hiperfagia/fisiopatologia , Hipogonadismo/etiologia , Hipogonadismo/fisiopatologia , Doenças Hipotalâmicas/diagnóstico , Doenças Hipotalâmicas/genética , Doenças Hipotalâmicas/fisiopatologia , Doenças Hipotalâmicas/cirurgia , Hormônios Hipotalâmicos/fisiologia , Hipotálamo/lesões , Doença Iatrogênica , Infertilidade/etiologia , Infertilidade/fisiopatologia , Leptina/deficiência , Leptina/genética , Leptina/fisiologia , Proteínas do Tecido Nervoso/deficiência , Proteínas do Tecido Nervoso/genética , Proteínas do Tecido Nervoso/fisiologia , Obesidade/genética , Obesidade/fisiopatologia , Obesidade/cirurgia , Neoplasias Hipofisárias/complicações , Neoplasias Hipofisárias/cirurgia , Complicações Pós-Operatórias/fisiopatologia , Pró-Opiomelanocortina/deficiência , Pró-Opiomelanocortina/genética , Pró-Opiomelanocortina/fisiologia , Puberdade Tardia/etiologia , Puberdade Tardia/fisiopatologia , Receptores para Leptina/deficiência , Receptores para Leptina/genética , Receptores para Leptina/fisiologia , Receptores de Melanocortina/deficiência , Receptores de Melanocortina/genética , Receptores de Melanocortina/fisiologia , Comportamento SedentárioRESUMO
Beta-defensins are antimicrobial peptides with an essential role in the innate immune response. In addition beta-defensins can also chemoattract cells involved in adaptive immunity. Until now, based on evidence from dendritic cell stimulation, human beta defensin-3 (hBD3) was considered pro-inflammatory. We present evidence here that hBD3 lacks pro-inflammatory activity in human and mouse primary Mphi. In addition, in the presence of LPS, hBD3 and the murine orthologue Defb14 (but not hBD2), effectively inhibit TNF-alpha and IL-6 accumulation implying an anti-inflammatory function. hBD3 also inhibits CD40/IFN-gamma stimulation of Mphi and in vivo, hBD3 significantly reduces the LPS-induced TNF-alpha level in serum. Recent work has revealed that hBD3 binds melanocortin receptors but we provide evidence that these are not involved in hBD3 immunomodulatory activity. This implies a dual role for hBD3 in antimicrobial activity and resolution of inflammation.
Assuntos
Tolerância Imunológica/imunologia , Inflamação/imunologia , beta-Defensinas/imunologia , 8-Bromo Monofosfato de Adenosina Cíclica/farmacologia , Sequência de Aminoácidos , Animais , Ligante de CD40/farmacologia , Células Cultivadas/imunologia , Endotoxemia/imunologia , Humanos , Interferon gama/farmacologia , Interleucina-10/fisiologia , Lipopolissacarídeos/toxicidade , Ativação de Macrófagos/efeitos dos fármacos , Macrófagos/imunologia , Masculino , Camundongos , Camundongos Endogâmicos BALB C , Camundongos Knockout , Dados de Sequência Molecular , Receptores de Melanocortina/deficiência , Receptores de Melanocortina/genética , Receptores de Melanocortina/fisiologia , Fator de Necrose Tumoral alfa/análise , beta-Defensinas/farmacologiaRESUMO
PURPOSE: The neuropeptide, alpha-melanocyte stimulating hormone (alpha-MSH), is an endogenous antagonist of inflammation. Injections of alpha-MSH peptide into inflamed tissues have been found to be very effective in suppressing autoimmune and endotoxin mediated diseases. We evaluated the potential to suppress ocular autoimmune disease (uveitis) by augmenting the expression of alpha-MSH through subconjunctival injections of naked adrenocorticotropic hormone amino acids 1-17 (ACTH1-17) plasmid. METHODS: We clinically scored the uveitis over time in B10.RIII, C57BL/6, and melanocortin 5 receptor knock-out (MC5r((-/-))) mice with experimental autoimmune uveitis (EAU) that were conjunctively injected with a naked DNA plasmid encoding ACTH1-17 at the time of EAU onset and three days later. The post-EAU retina histology of plasmid injected eyes was examined, and post-EAU concentrations of alpha-MSH in aqueous humor was assayed by ELISA. RESULTS: The subconjunctival injection of ACTH1-17 plasmid augmented the concentration of alpha-MSH in the aqueous humor of all post-EAU mice. The injection of ACTH1-17 suppressed the severity of EAU in the B10.RIII and C57BL/6 mice but the MC5r((-/-)) mice. In all the models of EAU, the ACTH1-17 injection helped to preserve the structural integrity of the retina; however, post-EAU aqueous humor was not immunosuppressive. CONCLUSIONS: The subconjunctival injection of the alpha-MSH expression vector ACTH1-17 plasmid is effective in suppressing EAU. The suppressive activity is dependent on MC5r expression, and possibly works though alpha-MSH antagonism of inflammation than on alpha-MSH directly modulating immune cells. The results suggest that an effective therapy for uveitis could include a gene therapy approach based on delivering alpha-MSH.
Assuntos
Doenças Autoimunes/imunologia , Terapia Genética , Terapia de Imunossupressão , Uveíte/imunologia , alfa-MSH/metabolismo , Hormônio Adrenocorticotrópico/genética , Animais , Anti-Inflamatórios/administração & dosagem , Humor Aquoso , Doenças Autoimunes/genética , Doenças Autoimunes/terapia , Proteínas do Olho/imunologia , Adjuvante de Freund , Humanos , Injeções , Camundongos , Camundongos Endogâmicos BALB C , Camundongos Endogâmicos C57BL , Camundongos Knockout , Modelos Animais , Fragmentos de Peptídeos/genética , Fragmentos de Peptídeos/imunologia , Plasmídeos , Engenharia de Proteínas , Receptores de Melanocortina/deficiência , Retina/imunologia , Retina/metabolismo , Retina/patologia , Proteínas de Ligação ao Retinol/imunologia , Uveíte/genética , Uveíte/terapia , Vacinas de DNA/administração & dosagem , alfa-MSH/genética , alfa-MSH/imunologiaRESUMO
POMC (pro-opiomelanocortin) is a complex polypeptide precursor which is cleaved into smaller biologically active peptides such as the melanocortins, alpha-, beta- and gamma-melanocyte-stimulating hormone. Data from human genetic and murine studies convincingly show that an intact central melanocortin signalling pathway is critical for normal energy homoeostasis. Not only does a loss of normal melanocortin signalling lead to obesity, but there are also data implicating increased melanocortin activity in the pathogenesis of cachexia. The study of POMC biology has lead to some fundamental insights into the mechanisms controlling food intake and body weight. This increased understanding of the physiological roles of the melanocortin system has opened up the potential for the design and development of rational therapies to treat perturbations in energy homoeostasis.